Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Scandinavian Journal of Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/03009749309099251PMID 8316776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.

  1993cited by this paper
• Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon.

  1992cited by this paper
• In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis.

  1991cited by this paper
• Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.

  1991cited by this paper
• The role of the white blood cell in arterial disease.

  1990cited by this paper
• Abnormal platelet aggregation in patients with Raynaud's phenomenon.

  1989cited by this paper
• Plasma eicosanoids, platelet function and cold sensitivity

  1989cited by this paper
• Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon.

  1988cited by this paper
• Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.

  1986cited by this paper
• Further studies on the role of red blood cells in spontaneous platelet aggregation.

  1985cited by this paper
• Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.

  1985cited by this paper
• Assessment of platelet function in patients with Raynaud's syndrome.

  1984cited by this paper
• Platelet aggregation studies in whole human blood.

  1983cited by this paper
• Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.

  1982cited by this paper
• Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.

  1982cited by this paper
• Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Plasma exchange and platelet function in Raynaud's phenomenon.

  1980cited by this paper
• Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon.

  1980cited by this paper
• Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis

  1979cited by this paper
• Prostacyclin is produced in whole blood [proceedings].

  1978cited by this paper
• Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis.

  1973cited by this paper
• Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

  1969cited by this paper
• Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets

  1961cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper

• Raynaud’s Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment

  2024cites this paper
• Repurposing cilostazol for Raynaud's phenomenon.

  2020cites this paper
• Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism

  2019cites this paper
• The Effects of Exercise on Vascular Physiologyin Systemic Sclerosis Patients

  2018cites this paper
• 2 Blood Platelets and Systemic Sclerosis

  2018cites this paper
• Therapeutic implications from the pathogenesis of Raynaud’s phenomenon

  2017cites this paper
• The role of botulinum toxin in vasospastic disorders of the hand.

  2015cites this paper
• Primary Raynaud’s Phenomenon

  2015cites this paper
• Therapeutic hypothermia after cardiac arrest in a patient with systemic sclerosis and Raynaud phenomenon.

  2015cites this paper
• The evaluation of mean platelet volume levels in patients with primary and secondary Raynaud's Phenomenon

  2014cites this paper
• Evaluating digital vascular perfusion and platelet dysfunction in Raynaud's phenomenon and systemic sclerosis

  2014cites this paper
• The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis

  2013cites this paper
• Platelet activation in patients with the Raynaud phenomenon

  2012cites this paper
• Blood Platelets and Systemic Sclerosis 31 4 . Platelets : Central actors of inflammation 4 . 1 Platelets transport bioactive mediators in the bloodstream

  2012cites this paper
• Blood Platelets and Systemic Sclerosis

  2012cites this paper
• Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition.

  2011cites this paper
• Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

  2010cites this paper
• Digital Ischemia in Scleroderma Spectrum of Diseases

  2010cites this paper
• Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing.

  2009cites this paper
• Raynaud's phenomenon: pathogenesis and management.

  2008cites this paper
• Úlceras digitales en la esclerosis sistémica

  2008cites this paper
• Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

  2008cites this paper
• [Therapeutic management of acral manifestations of systemic sclerosis].

  2007cites this paper
• [Manifestations of scleroderma at the hand--options for hand surgery in an interdisciplinary concept].

  2007cites this paper
• Therapeutisches Management akraler Manifestationen der systemischen Sklerose

  2007cites this paper
• Handbeteiligungen im Rahmen der progressiven systemischen Sklerodermie - Möglichkeiten der Handchirurgie im interdisziplinären Konzept

  2007cites this paper
• Increased circulating platelet–leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study

  2007cites this paper
• Endothelin-1, platelets and Raynaud's phenomenon.

  2006cites this paper
• Microvascular damage in systemic sclerosis: Detection and monitoring with biomarkers

  2006cites this paper
• Digital ulcers in patients with systemic sclerosis.

  2006cites this paper
• Pathogenesis of Raynaud's phenomenon.

  2005cites this paper
• Raynaud's phenomenon and serotonin reuptake inhibitors.

  2004cites this paper
• Erectile dysfunction and scleroderma.

  2004cites this paper
• Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.

  2003cites this paper
• A study of whole blood platelet and white cell aggregation using a laser flow aggregometer

  2003cites this paper
• Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.

  2003cites this paper
• Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis

  2003cites this paper
• Vascular Manifestations of Progressive Systemic Sclerosis

  2001cites this paper
• Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis.

  2001cites this paper
• New evidence for the spasm-of-resistance-vessel concept of ischemic diseases.

  1999cites this paper
• Autoimmunity and Vascular Involvement in Systemic Sclerosis (SSc)

  1999cites this paper
• Vascular Abnormalities in Raynaud's Phenomenon

  1999cites this paper
• Autoimmunity and vascular involvement in systemic sclerosis (SSc).

  1999cites this paper
• Cutaneous vascular infarcts secondary to spontaneous platelet aggregation

  1998cites this paper
• Raynaud's phenomenon: state of the art 1998.

  1998cites this paper
• The Aetiology of Raynaud's Phenomenon

  1998cites this paper
• VASCULAR REVIEW: The aetiology of Raynaud's phenomenon

  1998cites this paper
• Raynaud’s Phenomenon: State of the Art 1998

  1998cites this paper
• Primary Raynaud's is a disease or a disorder: it is not merely a trait.

  1998cites this paper
• The vascular endothelium in scleroderma.

  1995cites this paper
• Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

  1995cites this paper
• Markers of disease activity in systemic sclerosis.

  1994cites this paper
• Large vessel disease in CREST.

  1993cites this paper
• Physiology and Pathophysiology the Evaluation of Mean Platelet Volume Levels in Patients with Primary and Secondary Raynaud's Phenomenon

  year unknowncites this paper